Evidence map›Paper›PMID 37159397›Full record

ArticleJournal of the American Chemical Society2023

Global Discovery of Covalent Modulators of Ribonucleoprotein Granules.

Anthony M Ciancone, Kyung W Seo, Miaomiao Chen, Adam L Borne, Adam H Libby, Dina L Bai, Ralph E Kleiner, Ku-Lung Hsu

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Covalent PFKL Activator Suppresses Tumor Growth.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Imidazoles are Tunable Nucleofuges for Developing Tyrosine-Reactive Electrophiles.Chembiochem : a European journal of chemical biology · 2024
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anthony M CianconeDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
Kyung W SeoDepartment of Chemistry, Princeton University, Princeton, New Jersey 08544, United States.
Miaomiao ChenDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
Adam L BorneDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, United States.ORCID 0000-0001-5275-4195
Adam H LibbyDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
Dina L BaiDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
Ralph E KleinerDepartment of Chemistry, Princeton University, Princeton, New Jersey 08544, United States.ORCID 0000-0003-0508-9975
Ku-Lung HsuDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.ORCID 0000-0001-5620-3972
University of Virginia · USPrinceton University · USUniversity of Virginia Cancer Center

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Jay William FOX · 1987 to 2026
$72.1M
Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
Endocannabinoid Biosynthesis in Inflammation and PainR01DA043571 · NIDA · UNIVERSITY OF VIRGINIA · PI Ku-Lung Hsu · 2017 to 2026
$3.5M
Chemical Approaches to Illuminate the Epitranscriptome (Administrative/Equipment Supplement)R01GM132189 · NIGMS · PRINCETON UNIVERSITY · PI KLEINER, RALPH ELLIOT · 2019 to 2023
$1.6M
Defining and targeting substrate specificity of protein tyrosine phosphatasesR01GM144472 · NIGMS · UNIVERSITY OF VIRGINIA · PI HSU, KU-LUNG · 2022 to 2025
$1.6M
Tunable White Light Laser Confocal/Spectral Imaging MicroscopyS10RR025616 · NCRR · UNIVERSITY OF VIRGINIA · PI PERIASAMY, AMMASI · 2009 to 2009
$500k
NCI NIH HHS P30 CA044579NCI NIH HHS T32 CA009109NCRR NIH HHS S10 RR025616NIDA NIH HHS R01 DA043571NIGMS NIH HHS R01 GM132189NIGMS NIH HHS R01 GM144472
6 · The paper itself

Abstract

Stress granules (SGs) and processing-bodies (PBs, P-bodies) are ubiquitous and widely studied ribonucleoprotein (RNP) granules involved in cellular stress response, viral infection, and the tumor microenvironment. While proteomic and transcriptomic investigations of SGs and PBs have provided insights into molecular composition, chemical tools to probe and modulate RNP granules remain lacking. Herein, we combine an immunofluorescence (IF)-based phenotypic screen with chemoproteomics to identify sulfonyl-triazoles (SuTEx) capable of preventing or inducing SG and PB formation through liganding of tyrosine (Tyr) and lysine (Lys) sites in stressed cells. Liganded sites were enriched for RNA-binding and protein-protein interaction (PPI) domains, including several sites found in RNP granule-forming proteins. Among these, we functionally validate G3BP1 Y40, located in the NTF2 dimerization domain, as a ligandable site that can disrupt arsenite-induced SG formation in cells. In summary, we present a chemical strategy for the systematic discovery of condensate-modulating covalent small molecules.

Indexed as

Cytoplasmic GranulesDNA HelicasesPoly-ADP-Ribose Binding ProteinsProteomicsRNA HelicasesRNA Recognition Motif ProteinsDNA HelicasesPoly-ADP-Ribose Binding ProteinsRNA HelicasesRNA Recognition Motif Proteins

Identifiers

PMID37159397
PMCPMC10392812
OpenAlexW4376107225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.